Cerebrospinal fluid cytokine levels in migraine, tension-type headache and cervicogenic headache

Cephalalgia

Volumn 29, Issue 3, 2009, Pages 365-372

  Bo S H ^b,c   Davidsen, E M ^b   Gulbrandsen, P ^c,d   Dietrichs, E ^d,e   Bovim, G ^a,f   Stovner, L J ^a,f,g   White, L R ^a,f  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^b AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^c Helse Sør Øst Health Services Research Centre   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

^e OSLO UNIVERSITY HOSPITAL   (Norway)

^f NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^g NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

Cerebrospinal fluid; Cervicogenic headache; Cytokines; Episodic tension type hedache; Migraine

Indexed keywords

CYTOKINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; ARTICLE; CEREBROSPINAL FLUID; CERVICOGENIC HEADACHE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MIGRAINE AURA; OUTCOME ASSESSMENT; PAIN; SUBARACHNOID HEMORRHAGE; TENSION HEADACHE;

ADOLESCENT; ADULT; AGED; CHEMOKINE CCL2; CYTOKINES; FEMALE; HUMANS; INTERLEUKIN-10; MALE; MIDDLE AGED; MIGRAINE DISORDERS; POST-TRAUMATIC HEADACHE; RECEPTORS, INTERLEUKIN-1; TENSION-TYPE HEADACHE; TRANSFORMING GROWTH FACTOR BETA1;

EID: 59149104333     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2008.01727.x     Document Type: Article

References (35)

1. Landtblom AM, Fridriksson S, Boivie J, Hillman J, Johansson G, Johansson I. Sudden onset headache: a prospective study of features, incidence and causes. Cephalalgia 2002 22 : 354 60.
2. Linn FH, Rinkel GJ, Algra A, van Gijn J. Headache characteristics in subarachnoid haemorrhage and benign thunderclap headache. J Neurol Neurosurg Psychiatry 1998 65 : 791 3.
3. Cady R, Schreiber C, Farmer K, Sheftell F. Primary headaches: a convergence hypothesis. Headache 2002 42 : 204 16.
4. Antonaci F, Ghirmai S, Bono G, Sandrini G, Nappi G. Cervicogenic headache: evaluation of the original diagnostic criteria. Cephalalgia 2001 21 : 573 83.
5. Turkdogan D, Cagirici S, Soylemez D, Sur H, Bilge C, Turk U. Characteristic and overlapping features of migraine and tension-type headache. Headache 2006 46 : 461 8.
6. Kaniecki RG. Migraine and tension-type headache: an assessment of challenges in diagnosis. Neurology 2002 58 : S15 20.
7. Scharff L, Turk DC, Marcus DA. Triggers of headache episodes and coping responses of headache diagnostic groups. Headache 1995 35 : 397 403.
8. Chabriat H, Danchot J, Michel P, Joire JE, Henry P. Precipitating factors of headache. A prospective study in a national control-matched survey in migraineurs and nonmigraineurs. Headache 1999 39 : 335 8.
9. Bolay H, Reuter U, Dunn AK, Huang Z, Boas DA, Moskowitz MA. Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med 2002 8 : 136 42.
10. Buzzi MG, Bonamini M, Moskowitz MA. Neurogenic model of migraine. Cephalalgia 1995 15 : 277 80.
11. Waage A, Halstensen A, Shalaby R, Brandtzaeg P, Kierulf P, Espevik T. Local production of tumor necrosis factor α, interleukin 1, and interleukin 6 in meningococcal meningitis. Relation to the inflammatory response. J Exp Med 1989 170 : 1859 67.
12. Perini F, D'Andrea G, Galloni E, Pignatelli F, Billo G, Alba S et al. Plasma cytokine levels in migraineurs and controls. Headache 2005 45 : 926 31.
13. Sarchielli P, Alberti A, Baldi A, Coppola F, Rossi C, Pierguidi L et al. Proinflammatory cytokines, adhesion molecules, and lymphocyte integrin expression in the internal jugular blood of migraine patients without aura assessed ictally. Headache 2006 46 : 200 7.
14. van Hilten JJ, Ferrari MD, Van der Meer JW, Gijsman HJ, Looij BJ Jr. Plasma interleukin-1, tumour necrosis factor and hypothalamic-pituitary-adrenal axis responses during migraine attacks. Cephalalgia 1991 11 : 65 7.
15. Empl M, Sostak P, Riedel M, Schwarz M, Müller N, Forderreuther S, Straube A. Decreased sTNF-RI in migraine patients? Cephalalgia 2003 23 : 55 8.
16. Martelletti P, Stirparo G, Giacovazzo M. Proinflammatory cytokines in cervicogenic headache. Funct Neurol 1999 14 : 159 62.
17. Martelletti P, Stirparo G, Morrone S, Rinaldi C, Giacovazzo M. Inhibition of intercellular adhesion molecule-1 (ICAM-1), soluble ICAM-1 and interleukin-4 by nitric oxide expression in migraine patients. J Mol Med 1997 75 : 448 53.
18. Munno I, Marinaro M, Bassi A, Cassiano MA, Causarano V, Centonze V. Immunological aspects in migraine: increase of IL-10 plasma levels during attack. Headache 2001 41 : 764 7.
19. Ishizaki K, Takeshima T, Fukuhara Y, Araki H, Nakaso K, Kusumi M, Nakashima K. Increased plasma transforming growth factor 1 in migraine. Headache 2005 45 : 1224 8.
20. Kemper RH, Meijler WJ, Korf J, Ter Horst GJ. Migraine and function of the immune system: a meta-analysis of clinical literature published between 1966 and 1999. Cephalalgia 2001 21 : 549 57.
21. Losy J, Zaremba J. Monocyte chemoattractant protein-1 is increased in the cerebrospinal fluid of patients with ischemic stroke. Stroke 2001 32 : 2695 6.
22. Ossege LM, Sindern E, Voss B, Malin JP. Expression of tumor necrosis factor-α and transforming growth factor 1 in cerebrospinal fluid cells in meningitis. J Neurol Sci 1996 144 : 1 13.
23. Wilms H, Sievers J, Dengler R, Bufler J, Deuschl G, Lucius R. Intrathecal synthesis of monocyte chemoattractant protein-1 (MCP-1) in amyotrophic lateral sclerosis: further evidence for microglial activation in neurodegeneration. J Neuroimmunol 2003 144 : 139 42.
24. Fainardi E, Rizzo R, Melchiorri L, Vaghi L, Castellazzi M, Marzola A et al. Presence of detectable levels of soluble HLA-G molecules in CSF of relapsing-remitting multiple sclerosis: relationship with CSF soluble HLA-I and IL-10 concentrations and MRI findings. J Neuroimmunol 2003 142 : 149 58.
25. Borish LC, Steinke JW. 2. Cytokines and chemokines. J Allergy Clin Immunol 2003 111 (Suppl. 2 S460 75.
26. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders, 2nd edition. Cephalalgia 2004 24 (Suppl. 1 1 162.
27. Sjaastad O, Fredriksen TA, Pfaffenrath V. Cervicogenic headache: diagnostic criteria. The Cervicogenic Headache International Study Group. Headache 1998 38 : 442 5.
28. Stovner LJ, Kolstad F, Helde G. Radiofrequency denervation of facet joints C2-C6 in cervicogenic headache: a randomized, double-blind, sham-controlled study. Cephalalgia 2004 24 : 821 30.
29. Brookes ST, Whitley E, Peters TJ, Mulheran PA, Egger M, Davey Smith G. Subgroup analyses in randomised controlled trials: quantifying the risks of false-positives and false-negatives. Health Technol Assess 2001 5 : 1 56.
30. Schwartz BS, Stewart WF, Simon D, Lipton RB. Epidemiology of tension-type headache. JAMA 1998 279 : 381 3.
31. Miner JR, Smith SW, Moore J, Biros M. Sumatriptan for the treatment of undifferentiated primary headaches in the ED. Am J Emerg Med 2007 25 : 60 4.
32. Layé S, Lundkvist J, Bartfai T. Cytokines in the brain. In : Thèze J, ed. The cytokine network and immune functions. New York : Oxford University Press 1999 : 262 9.
33. Leonard EJ, Yoshimura T. Human monocyte chemoattractant protein-1 (MCP-1). Immunol Today 1990 11 : 97 101.
34. Rothwell NJ, Hopkins SJ. Cytokines and the nervous system II: actions and mechanisms of action. Trends Neurosci 1995 18 : 130 6.
35. Vitkovic L, Bockaert J, Jacque C. Inflammatory' cytokines: neuromodulators in normal brain? J Neurochem 2000 74 : 457 71.